Chemoimmunotherapy Combinations in Elderly Patients with Metastatic Non-Small Cell Lung Cancer and PD-L1 Expression < 50%: Results from an Italian Real-World Study.

J Clin Med · 2026 · PMC12898390 · PMID 41682846

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Similarly, in the CheckMate 9LA study, which included 70 patients (10%) aged ≥75 years, the treatment effect did not reach statistical significance and the HR did not favour the experimental arm receiving dual ICI blockade plus chemotherapy (HR 1.21, 95%CI 0.69–2.12) [ 8 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Chemoimmunotherapy Combinations in Elderly Patients with Metastatic Non-Small Cell Lung Cancer and PD-L1 Expression &lt; 50%: Results from an Italian Real-World Study.

The sentences

Chemoimmunotherapy Combinations in Elderly Patients with Metastatic Non-Small Cell Lung Cancer and PD-L1 Expression < 50%: Results from an Italian Real-World Study.